XORTX Therapeutics Inc. (CIK: 0001729214) EDGAR, Information, Filings... CompaniesBIO.Com

XORTX Therapeutics Inc.

Mailing address
SUITE 2400 - 745 THURLOW STREET, VANCOUVER, A1, V6E 0C5
Phone
403-607-2621
State location
A1
State of incorporation
N/A
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

XORTX Therapeutics Inc. (CIK: 0001729214) is an American company incorporated in the state of A1. Head office is located at SUITE 2400 - 745 THURLOW STREET, VANCOUVER, A1, V6E 0C5. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. XORTX Therapeutics Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XORTX Therapeutics Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001104659-24-128492 (33 Act) Size: KB	Dec-13-2024	333-269429 241549203
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-006897 (34 Act) Size: KB	Dec-12-2024	001-40858 241543556
EFFECT	Document	Acc-no: 9999999995-24-003574 (33 Act) Size: KB	Nov-25-2024	333-283275 241497968
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001171843-24-006531 (33 Act) Size: KB	Nov-22-2024	333-267328 241488273
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001171843-24-006530 (33 Act) Size: KB	Nov-22-2024	333-258741 241488255
F-1	Document	Registration statement for securities of certain foreign private issuers Acc-no: 0001104659-24-119763 (33 Act) Size: KB	Nov-15-2024	333-283275 241468738
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-006401 (34 Act) Size: KB	Nov-15-2024	001-40858 241466496
D	Document	Acc-no: 0001729214-24-000001 (33 Act) Size: KB	Oct-31-2024	021-528293 241412893
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-005803 (34 Act) Size: KB	Oct-24-2024	001-40858 241390794
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-24-109911 (34 Act) Size: KB	Oct-18-2024	001-40858 241381497
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-005701 (34 Act) Size: KB	Oct-18-2024	001-40858 241381462
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-24-109678 (34 Act) Size: KB	Oct-18-2024	001-40858 241378834
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001104659-24-109674 (33 Act) Size: KB	Oct-18-2024	333-269429 241378821
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-005677 (34 Act) Size: KB	Oct-17-2024	001-40858 241376340
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001104659-24-109381 (33 Act) Size: KB	Oct-17-2024	333-269429 241375949
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001171843-24-005570 (34 Act) Size: KB	Oct-09-2024	001-40858 241361710
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001171843-24-005322 (33 Act) Size: KB	Sep-24-2024	333-267328 241317483
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001171843-24-005321 (33 Act) Size: KB	Sep-24-2024	333-258741 241317472
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001171843-24-005320 (33 Act) Size: KB	Sep-24-2024	333-267328 241317461
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001171843-24-005324 (33 Act) Size: KB	Sep-24-2024	333-267328 241317460

Recent 20 filings. View all XORTX Therapeutics Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

XORTX Therapeutics Inc. overview
XORTX Therapeutics Inc. job
XORTX Therapeutics Inc. stock
XORTX Therapeutics Inc. ownership
XORTX Therapeutics Inc. CEO
XORTX Therapeutics Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.